Role of HLA-B(*)5101 binding nonamer peptides in formation of the HLA-Bw4 public epitope

International Immunology

Volumn 8, Issue 7, 1996, Pages 1027-1034

  Takamiya, Yuji ^a   Sakaguchi, Takashi ^a   Miwa, Kiyoshi ^b   Takiguchi, Masafumi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b AJINOMOTO CO INC   (Japan)

Author keywords

HLA B molecules; mAb; NKB1 receptor

Indexed keywords

EPITOPE; HLA B ANTIGEN; MONOCLONAL ANTIBODY; PEPTIDE;

AMINO ACID SEQUENCE; ARTICLE; HLA SYSTEM; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, MONOCLONAL; BIOPOLYMERS; CELL LINE; EPITOPES; FLOW CYTOMETRY; HLA-B ANTIGENS; L CELLS (CELL LINE); MICE; PEPTIDES; PROTEIN BINDING;

EID: 0030056104     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/8.7.1027     Document Type: Article

References (39)

1. Catipovic, B., Dal Porto, J., Mage, M., Johansen, T. E. and Schneck, J. P. 1992. Major histocompatibility complex conformational epitopes are peptide specific. J. Exp. Med. 176:1611.
2. Bluestone, J. A., Jameson, S., Miller, S. and Dick, R., II. 1992. Peptide-induced conformational changes in class I heavy chains alter major histocompatibility complex recognition. J. Exp. Med. 176:1757.
3. Sherman, L. A., Chattopadhyay, S., Biggs, J. A., Dick, R. F., II and Bluestone, J. A. 1993. Alloantibodies can discriminate class I major histocompatibility complex molecules associated with various endogenous peptides. Proc. Natl Acad. Sci. USA 90:6949.
4. Hogquist, K. A., Grandea, A. G., III and Bevan, M. J. 1993. Peptide variants reveal how antibodies recognize major histocompatibility complex class I. Eur. J. Immunol. 23:3028.
5. Duc, H. T., Rucay, P., Righenzi, S., Halle-Pannenko, O. and Kounlsky, P. 1993. Monoclonal antibodies directed against T cell epitopes presented by class I MHC antigens. Int. Immunol. 5:427
6. Solheim, J. C., Carreno, B. M., Myers, N. B., Lee, D. R. and Hansen, T. H. 1995. Peptide-induced rescue of serologic epitopes on class I MHC molecules. J. Immunol. 154:1188.
7. Fukazawa, T., Wang, J., Huang, F., Wen, J., Tyan, D., Williams, K. M., Raybourne, R. B. and Yu, D. T. Y. 1994. Testing the importance of each residue in a HLA-B27 binding peptide using monoclonal antibodies. J. Immunol. 152:1190.
8. Wang, J., Yu, D. T. Y., Fukazawa, T., Kellner, H., Wen, J., Cheng, X.-K., Roth, G., Williams, K. M. and Raybourne, R. B. 1994. A monoclonal antibody that recognizes HLA-B27 in the context of peptides. J. Immunol. 152:1197.
9. D'Amaro, J. 1975. W4(4a) and W6(4b) in diverse human populations. Demonstration of their genetic identity in populations and segregation studies. Tissue Antigens 5:386.
10. Ayres, J. and Cresswell, P. 1976. HLA-B specificities and w4, w6 specificities are on the same polypeptide. Eur. J. Immunol. 6:794.
11. Wan, A. M., Ennis, P., Parham, P. and Holmes, N. 1986. The primary structure of HLA-A32 suggests a region involved in formation of the Bw4/Bw6 epitopes. J. Immunol. 137:3671.
12. Sekimata, M., Hayashi, H., Nakayama, S., Kano, K. and Takiguchi, M. 1989. Serological demonstration of HLA-Bw4/Bw6 epitopes on hybrid molecules between HLA-B35 and HLA-B51. Immunogenetics 30:229.
13. Colonna, M., Spies, T., Strominger, J. L., Ciccone, E., Moretta, A., Moretta, L., Pende, D. and Viale, O. 1992. Alloantigen recognition by two human natural killer cell clones is associated with HLA-C or a closely linked gene. Proc. Natl Acad. Sci. USA 89:7983.
14. Colonna, M., Borsellino, G., Falco, M., Ferrara, G. B. and Strominger, J. L. 1993. HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells. Proc. Natl Acad. Sci. USA 90:12000.
15. Cella, M., Longo, A., Ferrara, G. B., Strominger, J. L. and Colonna, M. 1994. NK-3 specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isolecine 80. J. Exp. Med. 180:1235.
16. Litwin, V., Gumperz, J., Parham, P., Phillips, J. H. and Lanier, L. L. 1994. NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules. J. Exp. Med. 180:537.
17. Gumperz, J. E., Litwin, V., Phillips, J. H., Lanier, L. L. and Parham, P. 1995. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J. Exp. Med. 181:1133.
18. Malnati, M. S., Peruzzi, M., Parker, K. C., Biddison, W. E., Ciccone, E., Moretta, A. and Long, E. O. 1995. Peptide specificity in the recognition of MHC class I by natural killer cell clones. Science 267:1016.
19. Hayashi, H., Ennis, P. D., Ariga, H., Salter, R. D., Parham, P., Kano, K. and Takiguchi, M. 1989. HLA-B51 and HLA-Bw52 differ by only two amino acids which are in the helical region of the α1 domain. J. Immunol. 142:306.
20. Ooba, T., Hayashi, H., Karaki, S., Tanabe, M., Kano, K. and Takiguchi, M. 1989. The structure of HLA-B35 suggests that it is derived from HLA-Bw58 by two genetic mechanisms. Immunogenetics 30:76.
21. Karaki, S., Kariyone, A., Kato, N., Kano, K., Iwakura, Y. and Takiguchi, M. 1993. HLA-B51 transgenic mice as recipients for production of polymorphic anti-HLA-A, B antibodies. Immunogenetics 37:139.
22. Nakayama, S., Kawaguchi, G., Karaki, S., Nagao, T., Uchida, H., Kashiwase, K., Akaza, T., Nasuno, T. and Takiguchi, M. 1994. Effect of single amino acid substitution at residue 167 of HLA-B51 on binding of antibodies and recognition of T cells. Hum. Immunol. 39:211.
23. Müller, C. A., Engler-Blum, G., Gekeler, V., Steier, I., Weiss, E. and Schmidt, H. 1989. Genetic and serological heterogeneity of the supertypic HLA-B locus specificities Bw4 and Bw6. Immunogenetics 30:200.
24. D'Urso, C. M., Wang, Z., Cao, Y., Tatake, R., Zeff, R. A. and Ferrone, S. 1991. Lack of HLA class I antigen expression by cultured melanoma cells EO-1 due to a defect in β2m gene expression. J. Clin. Invest. 87:284.
25. Tanabe, M., Sekimata, M., Ferrone, S. and Takiguchi, M. 1992. Structural and functional analysis of monomorphic determinants recognized by monoclonal antibodies reacting with the HLA class I α3 domain. J. Immunol. 148:3202.
26. Nokihara, K., Yamamoto, R., Hazama, M., Wakizawa, O. and Nakamura, S. 1992. Design and applications of a novel simultaneous multiple solid-phase peptide synthesizer. In Epton, R., ed., Innovation and Perspectives in Solid-phase Synthesis, p. 445. Intercept, Andover.
27. Kikuchi, A., Sakaguchi, T., Miwa, K., Takamiya, Y., Rammensee, H.-G., Kaneko, Y. and Takiguchi, M. 1996. Binding of nonamer peptides to three HLA-B51 molecules which differ by a single amino acid substitution in the A-pocket. Immunogenetics 43:268.
28. Hayashi, H., Ooba, T., Nakayama, S., Sekimata, M., Kano, K. and Takiguchi, M. 1990. Allospecificities between HLA-B35 and HLA-Bw53 are generated by substitution of the residues associated with HLA-Bw4/Bw6 public epitopes. Immunogenetics 32:195.
29. Falk, K., Rötzschke, O., Takiguchi, M., Gnau, V., Stevanovic, S., Jung, G. and Rammensee, H.-G. 1995. Peptide motifs of HLA-B51, -B52 and -B78 molecules, and implications for Beçhet's disease. Int. Immunol. 7:223.
30. Falk, K., Rötzschke, O., Stevanovic, S., Jung, G. and Rammensee, H.-G. 1991. Allele-specific motifs revealed by sequencing of self-peptide eluted from MHC molecules. Nature 351:290.
31. Jardetzky, T. S., Lane, W. S., Robinson, R. A., Madden, D. R. and Wiley, D. C. 1991. Identification of self peptides bound to purified HLA-B27. Nature 353:326.
32. Rammensee, H.-G., Friede, T. and Stevanovic, S. 1995. MHC ligands and peptide motifs: first listing. Immunogenetics 41:178
33. Lutz, C. T., Smith, K. D., Greazel, N. S., Mace, B. E., Jensen, D. A., McCutcheon, J. A. and Goeken, N. E. 1994 Bw4-reactive and Bw6-reactive antibodies recognize multiple distinct HLA structures that partially overlap in the α-1 helix. J. Immunol. 153:4009.
34. Saper, M. A., Bjorkman, P. J. and Wiley, D. C. 1991. Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 Å resolution. J. Med. Biol. 219:277.
35. Madden, D. R., Gorga, J. C., Strominger, J. L. and Wiley, D. C. 1991. The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation. Nature 353:321.
36. Ferrini, S., Cambiaggi, A., Meazza, R., Sforzini, S., Marciano, S., Mingari, M. C. and Moretta, L. 1994. T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function. Eur. J. Immunol. 24:2294.
37. Mingari, M. C., Vitale, C., Cambiaggi, A., Schiavetti, F., Melioli, G., Ferrini, S. and Poggi, A. 1995. Cytolytic T lymphocytes displaying natural killer (NK)-like activity: expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production. Int. Immunol. 7:697
38. Nakajima, H., Tomiyama, H. and Takiguchi, M. 1995. Inhibition of γδ T cell recognition by receptors for MHC class I molecules. J. Immunol. 155:4139.
39. Phillips, J. H., Gumperz, J. E., Parham, P. and Lanier, L. L. 1995. Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes. Science 268:403.